IBNAX
Price
$24.73
Change
+$0.11 (+0.45%)
Updated
Jun 27 closing price
Net Assets
1.59B
RLBGX
Price
$36.53
Change
+$0.09 (+0.25%)
Updated
Jun 27 closing price
Net Assets
249.42B
Interact to see
Advertisement

IBNAX vs RLBGX

Header iconIBNAX vs RLBGX Comparison
Open Charts IBNAX vs RLBGXBanner chart's image
Macquarie Balanced Fund
Price$24.73
Change+$0.11 (+0.45%)
VolumeN/A
Net Assets1.59B
American Funds American Balanced R6
Price$36.53
Change+$0.09 (+0.25%)
VolumeN/A
Net Assets249.42B
IBNAX vs RLBGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IBNAX vs. RLBGX commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBNAX is a StrongBuy and RLBGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 249B vs. IBNAX (1.59B). RLBGX pays higher dividends than IBNAX: RLBGX (2.23) vs IBNAX (0.98). IBNAX was incepted earlier than RLBGX: IBNAX (38 years) vs RLBGX (16 years). IBNAX (1.08) is less costly to investors than RLBGX (0.25). IBNAX is a more actively managed with annual turnover of: 76.00 vs. RLBGX (44.00). RLBGX has a lower initial minimum investment than IBNAX: RLBGX (250) vs IBNAX (1000). IBNAX annual gain was more profitable for investors over the last year : 11.59 vs. RLBGX (7.96). RLBGX return over 5 years is better than : 45.12 vs. IBNAX (13.18).
IBNAXRLBGXIBNAX / RLBGX
Total Expense Ratio1.060.25424%
Annual Report Gross Expense Ratio1.080.25432%
Fund Existence38 years16 years-
Gain YTD5.7707.17480%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.59B249B1%
Annual Yield % from dividends0.982.2344%
Returns for 1 year11.597.96146%
Returns for 3 years14.5535.3141%
Returns for 5 years13.1845.1229%
Returns for 10 years6.5567.3910%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLRO5.520.28
+5.34%
ClearOne Inc
NUVL79.680.55
+0.70%
Nuvalent
EWTX13.150.09
+0.69%
Edgewise Therapeutics
BMO109.120.02
+0.02%
Bank of Montreal
SOPH3.09-0.01
-0.32%
SOPHiA GENETICS SA